Silly Season Continues for Biotech By Bret Jensen | Mar 1, 2016 | 10:00 AM EST | Valuations of some small-cap concerns, such as Relypsa, are ridiculously cheap.
Cramer: Ford Sales Were Spectacular; Is Recession off the Table? By Jim Cramer | Mar 1, 2016 | 11:05 AM EST | The peak auto thesis was among the most worrisome issues.
This Is a Great, Low Risk Time to Get Into the Market By Mike Norman | Mar 1, 2016 | 2:00 PM EST | I love it when the market is climbing the wall of worry.
By Bret Jensen | Mar 1, 2016 | 10:00 AM EST | Valuations of some small-cap concerns, such as Relypsa, are ridiculously cheap.
By Jim Cramer | Mar 1, 2016 | 11:05 AM EST | The peak auto thesis was among the most worrisome issues.
By Mike Norman | Mar 1, 2016 | 2:00 PM EST | I love it when the market is climbing the wall of worry.
By James "Rev Shark" DePorre | Mar 1, 2016 | 1:46 PM EST | The big challenge remains finding places to put money.